Literature DB >> 15786453

Antemortem diagnosis of frontotemporal lobar degeneration.

David S Knopman1, Bradley F Boeve, Joseph E Parisi, Dennis W Dickson, Glenn E Smith, Robert J Ivnik, Keith A Josephs, Ronald C Petersen.   

Abstract

The objective of this article is to study the accuracy of antemortem clinical diagnoses of frontotemporal lobar degenerations (FTLDs). From brain autopsies performed on subjects enrolled in the Mayo Alzheimer Center between 1991 and 2003, cases with neuropathological diagnoses of FTLD were identified. Neuropathological diagnoses of FTLDs were based on consensus criteria for FTLD. The initial clinical histories, neuropsychological test results, brain imaging studies, and initial clinical diagnoses were reviewed. There were 34 pathological FTLD cases among 433 subjects who underwent autopsy; 29 of these 34 cases were diagnosed as FTLD antemortem based on the sum of clinical, neuropsychological, and imaging features (sensitivity, 85%). The specificity was 99%. Among the 34 cases with pathological FTLD, 27 (79%) had clinical histories diagnostic of an FTLD syndrome, 20 (62%) had neuropsychological profiles consistent with FTLD, 17 (50%) had magnetic resonance scans consistent with FTLD, and 7 of 8 who had functional imaging studies had ones consistent with FTLD. In those with incorrect antemortem diagnoses, three were thought to have Alzheimer's disease, one was considered hard to classify, and one was diagnosed with vascular dementia. The antemortem consensus diagnosis of FTLD was moderately sensitive and very specific. With experienced clinicians and awareness of the unique manifestations of FTLD, accurate antemortem diagnosis was feasible.

Entities:  

Mesh:

Year:  2005        PMID: 15786453     DOI: 10.1002/ana.20425

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  61 in total

1.  Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?

Authors:  Jeanne A Teresi; Ellen Grober; Joseph P Eimicke; Amy R Ehrlich
Journal:  Psychol Assess       Date:  2012-02-06

2.  Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Fabrizio Vecchio; Roberta Lizio; Michela Pievani; Geroldi Cristina; Claudia Fracassi; Fabrizio Vernieri; Guido Rodriguez; Flavio Nobili; Raffaele Ferri; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2010-12-22       Impact factor: 5.038

3.  An algorithm for genetic testing of frontotemporal lobar degeneration.

Authors:  J S Goldman; R Rademakers; E D Huey; A L Boxer; R Mayeux; B L Miller; B F Boeve
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

4.  Extrapyramidal signs in the primary progressive aphasias.

Authors:  Sarah A Kremen; Mario F Mendez; Po-Heng Tsai; Edmond Teng
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-02       Impact factor: 2.035

5.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

6.  Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

Authors:  C Davatzikos; S M Resnick; X Wu; P Parmpi; C M Clark
Journal:  Neuroimage       Date:  2008-04-08       Impact factor: 6.556

7.  Are subjective cognitive complaints a risk factor for dementia?

Authors:  Roberto Gallassi; Federico Oppi; Roberto Poda; Simona Scortichini; Michelangelo Stanzani Maserati; Gianfranco Marano; Luisa Sambati
Journal:  Neurol Sci       Date:  2010-02-25       Impact factor: 3.307

8.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment.

Authors:  A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

9.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

10.  CSF biomarkers in frontotemporal lobar degeneration with known pathology.

Authors:  H Bian; J C Van Swieten; S Leight; L Massimo; E Wood; M Forman; P Moore; I de Koning; C M Clark; S Rosso; J Trojanowski; V M-Y Lee; M Grossman
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.